Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$27,000.00

Investigating dopamine D1-D2 receptor heteromer neuron specific mechanisms of psychiatric disorder pathology in human post-mortem striatum

EF 2024-25

Résumé
The cause of major depressive disorder (MDD) and the reason why females are two-times more likely to develop MDD compared to males remains unknown. The George Lab has established that activation of dopamine D1-D2 receptor complex (D1-D2R) increased anxiety and depressive-like behaviours and blocking the complex reduced these behaviours in rodent models of depression. Further, adult females have higher-levels of striatal (brain region) D1-D2R expression compared to males which may underlie increased female depression-like susceptibility. Therefore, our goal is to investigate whether D1-D2R levels and their pro-depressive downstream molecules are altered in a sex and cell-type dependent manner in human post-mortem striatum and elevated in patients with a history of MDD. Objective 1: Determine the age of onset and time-course of development of sex-specific differences in D1-D2R expression. This will help decipher the role of D1-D2R and establish when the male/female differences are established. Objective 2: Develop and validate a multiplex immunohistochemistry (mIHC) protocol in naive rat brain-tissue. Cell-type specific D1-D2R expression and its downstream pro-depressive signalling proteins will be analyzed. Fluorescence Resonance Energy Transfer (FRET) will help determine D1-D2R density and receptor-receptor distance within the complex. Objective 3: Conduct mIHC on post-mortem human brain striatum samples from individuals of both sexes with MDD without psychosis and their matched control subjects. Upon validation of mIHC and FRET in rat, cell-type specific expression of D1-D2R and downstream proteins will be evaluated in human samples. Results from this project will aid in defining the role of D1-D2R signalling in MDD etiology for novel anti-depressant development.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
530201
Name
Ali Maqdis
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating dopamine D1-D2 receptor heteromer neuron specific mechanisms of psychiatric disorder pathology in human post-mortem striatum
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Anxiety; Brain; Depression; Dopamine; Heteromer; Human; Psychiatry; Rat; Sex-Differences; Striatum
Abstract
The cause of major depressive disorder (MDD) and the reason why females are two-times more likely to develop MDD compared to males remains unknown. The George Lab has established that activation of dopamine D1-D2 receptor complex (D1-D2R) increased anxiety and depressive-like behaviours and blocking the complex reduced these behaviours in rodent models of depression. Further, adult females have higher-levels of striatal (brain region) D1-D2R expression compared to males which may underlie increased female depression-like susceptibility. Therefore, our goal is to investigate whether D1-D2R levels and their pro-depressive downstream molecules are altered in a sex and cell-type dependent manner in human post-mortem striatum and elevated in patients with a history of MDD. Objective 1: Determine the age of onset and time-course of development of sex-specific differences in D1-D2R expression. This will help decipher the role of D1-D2R and establish when the male/female differences are established. Objective 2: Develop and validate a multiplex immunohistochemistry (mIHC) protocol in naive rat brain-tissue. Cell-type specific D1-D2R expression and its downstream pro-depressive signalling proteins will be analyzed. Fluorescence Resonance Energy Transfer (FRET) will help determine D1-D2R density and receptor-receptor distance within the complex. Objective 3: Conduct mIHC on post-mortem human brain striatum samples from individuals of both sexes with MDD without psychosis and their matched control subjects. Upon validation of mIHC and FRET in rat, cell-type specific expression of D1-D2R and downstream proteins will be evaluated in human samples. Results from this project will aid in defining the role of D1-D2R signalling in MDD etiology for novel anti-depressant development.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ali, Maqdis
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~